These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2585033)

  • 1. A comparison of two assays for the in vitro chemosensitivity testing of human acute non-lymphoblastic leukemia cells.
    Dal Pozzo O; Bernabei PA; Santini V; Saccardi R; Santini S; Rossi Ferrini P
    J Chemother; 1989 Oct; 1(5):318-23. PubMed ID: 2585033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro chemosensitivity testing of leukemic cells: prediction of response to chemotherapy in patients with acute non-lymphocytic leukemia.
    Santini V; Bernabei PA; Silvestro L; Dal Pozzo O; Bezzini R; Viano I; Gattei V; Saccardi R; Ferrini PR
    Hematol Oncol; 1989; 7(4):287-93. PubMed ID: 2737608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro chemosensitivity testing of leukemic cells: development of a semiautomated colorimetric assay.
    Bernabei PA; Santini V; Silvestro L; Dal Pozzo O; Bezzini R; Viano I; Gattei V; Saccardi R; Rossi Ferrini P
    Hematol Oncol; 1989; 7(3):243-53. PubMed ID: 2707746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test.
    Hwang WS; Chen LM; Huang SH; Wang CC; Tseng MT
    Leuk Res; 1993 Aug; 17(8):685-8. PubMed ID: 8355513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia.
    Sargent JM; Taylor CG
    Br J Cancer; 1989 Aug; 60(2):206-10. PubMed ID: 2765367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of 17 cases of non-lymphoblastic acute leukemia with a combination of daunorubicin, cytosine and arabinoside].
    Dini E; Barbui T; Cartei G; Chisesi T; Cazzavillan M; Battista R
    Minerva Med; 1975 Jul; 66(52):2619-2620. PubMed ID: 1057055
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing.
    Ford CH; Richardson VJ; Tsaltas G
    Cancer Chemother Pharmacol; 1989; 24(5):295-301. PubMed ID: 2788039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequencing of cytosine arabinoside (NSC-63878) and daunorubicin (NSC-82151) in acute myelogenous leukemia.
    Omura GA
    Cancer Treat Rep; 1976 May; 60(5):629-31. PubMed ID: 1068745
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia.
    Marie JP; Zittoun R; Thevenin D
    Br J Cancer; 1988 Nov; 58(5):570-4. PubMed ID: 3219266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of blast cell survival and proliferation to chemotherapy resistance in AML.
    Nørgaard JM; Langkjer ST; Palshof T; Clausen N; Pedersen B; Hokland P
    Br J Haematol; 1996 Jun; 93(4):888-97. PubMed ID: 8703822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Letter: Acute myeloblastic leukemia: prevision of the efficiency by the combination of daunorubicin-cytosine-arabinoside].
    Zittoun R
    Nouv Presse Med; 1975 Jun; (23):1733. PubMed ID: 1099534
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro short-term sensitivity test for the prediction of response to chemotherapy in acute non-lymphocytic leukemia.
    Saccardi R; Bernabei PA; Bezzini R; Agostino FC; Leoni F; Rossi Ferrini P
    Chemioterapia; 1988 Jun; 7(3):173-8. PubMed ID: 3168072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.
    Klumper E; Pieters R; Kaspers GJ; Huismans DR; Loonen AH; Rottier MM; van Wering ER; van der Does-van den Berg A; Hählen K; Creutzig U
    Leukemia; 1995 Nov; 9(11):1864-9. PubMed ID: 7475276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro drug sensitivity of leukemic progenitors and P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome.
    Basara N; Radosević-Radojković N; Colović M; Bosković D; Rolović Z
    Eur J Haematol; 1995 Aug; 55(2):83-7. PubMed ID: 7628594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
    Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB
    Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cytosine arabinoside on DNA synthesis as predictor for acute myelocytic leukemia (AML) patients' response to chemotherapy.
    Epstein J; Preisler H
    Eur J Cancer (1965); 1981 Jun; 17(6):623-8. PubMed ID: 6946929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
    Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
    Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.